圣诺生物
(688117)
| 流通市值：36.48亿 | | | 总市值：36.48亿 |
| 流通股本：1.12亿 | | | 总股本：1.12亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 184,337,043.36 | 456,070,000.1 | 337,836,114.63 | 198,937,738.87 |
| 营业收入 | 184,337,043.36 | 456,070,000.1 | 337,836,114.63 | 198,937,738.87 |
| 二、营业总成本 | 125,838,852.95 | 382,688,895.04 | 272,013,119.71 | 176,467,279.26 |
| 营业成本 | 80,919,678.44 | 191,704,265.08 | 138,539,550.35 | 80,403,223.79 |
| 税金及附加 | 1,284,091.71 | 4,696,116.51 | 3,166,909.96 | 2,578,861.95 |
| 销售费用 | 13,451,348.97 | 66,257,444.57 | 49,354,000.33 | 35,677,629.03 |
| 管理费用 | 22,429,906.19 | 61,663,769.41 | 45,280,270.26 | 30,481,157.65 |
| 研发费用 | 4,839,101.81 | 49,165,159.73 | 28,578,274.28 | 23,832,884.61 |
| 财务费用 | 2,914,725.83 | 9,202,139.74 | 7,094,114.53 | 3,493,522.23 |
| 其中:利息费用 | 3,282,676.79 | 11,908,840.85 | 8,955,940.93 | 5,267,331.5 |
| 其中:利息收入 | 156,899.2 | 2,034,608.76 | 1,708,002.98 | 1,231,947.24 |
| 加:公允价值变动收益 | -132,000 | 157,000 | - | - |
| 加:投资收益 | 2,029,283.39 | 1,715,684.86 | 624,137.28 | 697,983.61 |
| 资产处置收益 | - | - | -3,717.56 | 35 |
| 资产减值损失(新) | -4,640,498.92 | -10,876,019.72 | -4,721,467.96 | -4,751,478.35 |
| 信用减值损失(新) | 534,298.32 | -7,233,528.39 | -943,025.01 | 1,954,459.15 |
| 其他收益 | 478,046 | 4,916,296.86 | 3,603,264.22 | 3,435,789.64 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 56,767,319.2 | 62,060,538.67 | 64,382,185.89 | 23,807,248.66 |
| 加:营业外收入 | 268 | 245,594.78 | 207,582.21 | 26,106.26 |
| 减:营业外支出 | 1,245,988.12 | 797,583.33 | 668,773.22 | 533,423.43 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 55,521,599.08 | 61,508,550.12 | 63,920,994.88 | 23,299,931.49 |
| 减:所得税费用 | 8,440,736.82 | 11,673,177.63 | 7,104,987.68 | 1,581,627.39 |
| 六、净利润 | 47,080,862.26 | 49,835,372.49 | 56,816,007.2 | 21,718,304.1 |
| 持续经营净利润 | 47,080,862.26 | 49,835,372.49 | 56,816,007.2 | 21,718,304.1 |
| 归属于母公司股东的净利润 | 47,119,700.22 | 50,023,708.92 | 56,946,626.77 | 21,787,611.98 |
| 少数股东损益 | -38,837.96 | -188,336.43 | -130,619.57 | -69,307.88 |
| (一)基本每股收益 | 0.42 | 0.45 | 0.51 | 0.19 |
| (二)稀释每股收益 | 0.43 | 0.44 | 0.51 | 0.19 |
| 九、综合收益总额 | 47,080,862.26 | 49,835,372.49 | 56,816,007.2 | 21,718,304.1 |
| 归属于母公司股东的综合收益总额 | 47,119,700.22 | 50,023,708.92 | 56,946,626.77 | 21,787,611.98 |
| 归属于少数股东的综合收益总额 | -38,837.96 | -188,336.43 | -130,619.57 | -69,307.88 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-29 | 2024-07-31 |
| 审计意见(境内) | | 标准无保留意见 | | |